RecruitingISRCTN17178652
Assessing the effectiveness of lithium plus quetiapine compared to lithium alone or quetiapine alone for treatment of adults with Bipolarity
A short description of this study’s research objective has not yet been verified.
Research studyAges 18–100United Kingdom
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 100 years. Other eligibility criteria apply.
- Listed locations
- United Kingdom
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of Birmingham
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 18 Years to 100 Years
- Official registry ID
- ISRCTN17178652
- Official title
- Assessing the effectiveness of lithium plus quetiapine compared to lithium alone or quetiapine alone for treatment of adults with Bipolarity
Study ID: ISRCTN17178652. We help you review the study, but cannot decide medical eligibility.
Recruitment & locations
RecruitingUnited Kingdom
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of Birmingham, a university.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 100 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me